NF-κB inhibition reduces the release of cytokines by bone marrow stromal cells important for growth and survival of MM cells, thereby disrupting the cytoprotective effects of BM microenvironment on MM cells [101]. This evidence concerns the gene NFKB1 and Miyoshi myopathy.